# Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis

> **NCT02071043** · PHASE2 · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 48 (actual)

## Conditions studied

- Advanced Gastric Cancer

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT02071043
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02071043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02071043, "Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02071043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*